Does STAVUDINE Cause Lipodystrophy acquired? 283 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 283 reports of Lipodystrophy acquired have been filed in association with STAVUDINE. This represents 10.9% of all adverse event reports for STAVUDINE.
283
Reports of Lipodystrophy acquired with STAVUDINE
10.9%
of all STAVUDINE reports
0
Deaths
31
Hospitalizations
How Dangerous Is Lipodystrophy acquired From STAVUDINE?
Of the 283 reports, 31 (11.0%) required hospitalization.
Is Lipodystrophy acquired Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for STAVUDINE. However, 283 reports have been filed with the FAERS database.
What Other Side Effects Does STAVUDINE Cause?
Virologic failure (408)
Drug resistance (361)
Foetal exposure during pregnancy (343)
Viral mutation identified (258)
Treatment failure (255)
Pathogen resistance (196)
Mitochondrial toxicity (180)
Eyelid ptosis (168)
Diplopia (166)
Pregnancy (131)
What Other Drugs Cause Lipodystrophy acquired?
LAMIVUDINE (383)
ZIDOVUDINE (313)
NEVIRAPINE (288)
RITONAVIR (254)
LOPINAVIR\RITONAVIR (230)
DIDANOSINE (216)
TENOFOVIR DISOPROXIL (205)
EFAVIRENZ (203)
INDINAVIR (195)
ABACAVIR (194)
Which STAVUDINE Alternatives Have Lower Lipodystrophy acquired Risk?
STAVUDINE vs STELARA
STAVUDINE vs STIRIPENTOL
STAVUDINE vs STIVARGA
STAVUDINE vs STRATTERA
STAVUDINE vs STREPTOCOCCUS PNEUMONIAE TYPE 1 CAPSULAR POLYSACCHARIDE DIPHTHERIA CRM197 PROTEIN CONJUGATE ANTIGEN\STREPTOCOCCUS PNEUMONIAE TYPE 14 CAPSULAR POLYSACCHARIDE DIPHTHERIA CRM197 PROTEIN CONJUGATE ANTIGEN\STREPTOCOCCUS PNEUMONIAE TYPE 18C CAPSULAR POLYSACCHARIDE DIPHTHERIA CRM197 PROTEIN CONJUGATE ANTIGEN\STREPTOCOCCUS PNEUMONIAE TYPE 19A CAPSULAR POLYSACCHARIDE DIPHTHERIA CRM197 PROTEIN CONJUGATE ANTIGEN\STREPTOCOCCUS PNEUMONIAE TYPE 19F CAPSULAR POLYSACCHARIDE DIPHTHERIA CRM197 PROTEIN CONJUGATE A